Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0000605
UniProt IDQ9NPF2
Primary gene name(s)CHST11
Synonym gene name(s)unknown
Protein nameCarbohydrate sulfotransferase 11
Protein functionCatalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine, GalNAc residue of chondroitin. Chondroitin sulfate constitutes the predominant proteoglycan present in cartilage and is distributed on the surfaces of many cells and extracellular matrices. Can also sulfate Gal residues in desulfated dermatan sulfate. Preferentially sulfates in GlcA->GalNAc unit than in IdoA->GalNAc unit. Does not form 4, 6-di-O-sulfated GalNAc when chondroitin sulfate C is used as an acceptor.
Subcellular locationGolgi apparatus membrane {ECO:0000250};
Single-pass type II membrane protein {ECO:0000250}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q9NPF2
Gene Ontology
(Biological Process)
Complete annatation
carbohydrate biosynthetic process [GO:0016051];
chondrocyte development [GO:0002063];
chondroitin sulfate biosynthetic process [GO:0030206];
developmental growth [GO:0048589];
embryonic digit morphogenesis [GO:0042733];
embryonic viscerocranium morphogenesis [GO:0048703];
negative regulation of apoptotic process [GO:0043066];
negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512];
polysaccharide localization [GO:0033037];
post-anal tail morphogenesis [GO:0036342];
post-embryonic development [GO:0009791];
regulation of cell proliferation [GO:0042127];
respiratory gaseous exchange [GO:0007585]
Gene Ontology
(Molecular Function)
Complete annatation
chondroitin 4-sulfotransferase activity [GO:0047756];
N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537];
N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]
Gene Ontology
(Cellular Component)
Complete annatation
Golgi membrane [GO:0000139];
integral component of membrane [GO:0016021];
membrane [GO:0016020]
Protein-protein interaction119084
Phylogenetic treeQ9NPF2
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.07097089869409990.828259095246380.883226339575028
AZA vs. DISU0.1208487061241430.633260766906520.960057478314726
AZA vs. IL70.2411270555659030.2100895352074240.975813304494481
AZA vs. SAHA-0.04186475114837630.863728908522630.967874633293944
DISU vs. CD30.03752442226539040.9176442607628890.946852596806064
DISU vs. IL70.1108040712289480.6601522584273540.904051171492766
DISU vs. SAHA-0.1605191302241330.5822690607172580.865450534935323
DMSO vs. AZA-0.03989367695275890.8119973128882471
DMSO vs. CD3-0.1197377554652350.7078683327599230.786201447436467
DMSO vs. DISU-0.161900807138240.5074249329898160.910713490843564
DMSO vs. IL70.2879960655575090.1095642970473390.594771976229253
DMSO vs. SAHA-0.008535653310506960.9711151645190710.993292390076406
HIV vs. Mock in Activation0.3319152973710540.5938146980834780.999983755607037
HIV vs. Mock in Latency0.2355706244100640.153566291295890.999834320637052
IL7 vs. CD30.1762299717647230.5831147232757090.702580993120285
SAHA vs. CD3-0.1365972031339640.6987506615288880.779469678550903
SAHA vs. IL7-0.2852849011743740.2416425380324960.483862861092169
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
-0.3306 0.03413

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.333833 0.0105545
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.802 0.722 0.351 0.434 0.706
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00532 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human)